Literature DB >> 11530860

The immunolocalization of Bcl-2 in human term placenta.

R Axt-Fliedner1, M Friedrich, A Kordina, C Wasemann, D Mink, K Reitnauer, W Schmidt.   

Abstract

PURPOSE: To study the immunolocalization of the Bcl-2 protein in formalin-fixed placental tissue collected from uncomplicated term pregnancies.
METHODS: A total of 19 human term placentas of 38-41 weeks' gestation, 11 obtained from spontaneous deliveries and eight from elective caesarean sections prior to labour were included. Sections were incubated with an antibody to the Bcl-2 protein and light microscopy was used to evaluate Bcl-2 staining.
RESULTS: The anti-apoptotic Bcl-2 protein was expressed diffusely throughout the cytoplasm of the syncytiotrophoblast with much less intensive staining in cytotrophoblast and mesenchymal cells. Bcl-2 expression was reduced or lost in areas of syncytial sprouts. No differences in Bcl-2 staining were observed between placentas obtained after spontaneous deliveries and those collected before the onset of labour after elective caesarean section.
CONCLUSION: Expression of the anti-apoptotic Bcl-2 protein in human term placenta does not seem to be influenced by parturition. Additionally, Bcl-2 expression might be an important factor in the regulation of apoptosis in the human trophoblast and thus in maintaining placental function during gestation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530860

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  2 in total

1.  Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction.

Authors:  Ian P Crocker; Suzanne Cooper; Stephen C Ong; Philip N Baker
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Elevated microRNA-34a contributes to trophoblast cell apoptosis in preeclampsia by targeting BCL-2.

Authors:  M Guo; X Zhao; X Yuan; P Li
Journal:  J Hum Hypertens       Date:  2017-10-12       Impact factor: 3.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.